» Articles » PMID: 1615755

Interleukin-6: an Osteotropic Factor?

Overview
Date 1992 May 1
PMID 1615755
Citations 37
Authors
Affiliations
Soon will be listed here.
Citing Articles

Drug Investigation to Dampen the Comorbidity of Rheumatoid Arthritis and Osteoporosis via Molecular Docking Test.

Oh K, Adnan M, Cho D Curr Issues Mol Biol. 2022; 44(3):1046-1061.

PMID: 35723292 PMC: 8947408. DOI: 10.3390/cimb44030069.


Interleukin-6 Knockout Inhibits Senescence of Bone Mesenchymal Stem Cells in High-Fat Diet-Induced Bone Loss.

Li Y, Lu L, Xie Y, Chen X, Tian L, Liang Y Front Endocrinol (Lausanne). 2021; 11:622950.

PMID: 33679606 PMC: 7933660. DOI: 10.3389/fendo.2020.622950.


The effects of intraperitoneal metoprolol administration on healing of bone defects in rat tibia: a pilot study.

Al Alawy R, Hammad H, AlHabashneh R Clin Oral Investig. 2019; 24(3):1239-1247.

PMID: 31317257 DOI: 10.1007/s00784-019-02987-w.


EMMPRIN Inhibits bFGF-Induced IL-6 Secretion in an Osteoblastic Cell Line, MC3T3-E1.

Saiki A, Motoyoshi M, Motozawa K, Okamura T, Ueki K, Shimizu N Int J Med Sci. 2017; 14(12):1173-1180.

PMID: 29104472 PMC: 5666549. DOI: 10.7150/ijms.20387.


Emerging Roles of Osteoclasts in the Modulation of Bone Microenvironment and Immune Suppression in Multiple Myeloma.

Mansour A, Wakkach A, Blin-Wakkach C Front Immunol. 2017; 8:954.

PMID: 28848556 PMC: 5554508. DOI: 10.3389/fimmu.2017.00954.